Some common medications can lead to vitamin and mineral deficiencies. Learn which drugs can interact in this way.

CVS says the decision to cover Wegovy and exclude Zepbound is “forcing the drug manufacturers to compete with one another” and will encourage both Eli Lilly and Novo Nordisk to lower prices for ... a ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

Policymakers will need to address the true drivers of high drug prices here at home, while simultaneously pressing our allies to contribute more abroad, writes PhRMA’s Steve Ubl.

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing dementia.

On April 15, 2025, President Donald Trump issued Executive Order No. 14273, “Lowering Drug Prices by Once Again Putting Americans First, ” which outlines a series of targeted actions to lower ...

Merck's oral PCSK9 inhibitor enlicitide showed significant LDL-C reductions in two Phase 3 trials, with no major safety concerns reported.

Researchers are beginning to wonder whether blockbuster drugs such as Wegovy, Ozempic and Zepbound could play a role in preventing cancer.

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing cancer. A new study released Thursday suggests there’s a slightly lower ...

Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in ...

Business Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Boxes for the medications Wegovy and Zepbound are arranged for a photograph in California on May 8, 2025.